サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1766989

フィデューシャルマーカーの世界市場

Fiducial Markers

出版日
ページ情報
英文 378 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
フィデューシャルマーカーの世界市場
出版日: 2025年07月10日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 378 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

フィデューシャルマーカーの世界市場は2030年までに1億6,640万米ドルに達する見込み

2024年に1億2,380万米ドルと推定されるフィデューシャルマーカーの世界市場は、2024年から2030年にかけてCAGR 5.1%で成長し、2030年には1億6,640万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである金属は、CAGR 5.8%を記録し、分析期間終了時には7,620万米ドルに達すると予測されます。ポリマーセグメントの成長率は、分析期間でCAGR 4.6％と推定されます。

米国市場は3,230万米ドルと推定、中国はCAGR 8.0％で成長予測

米国のフィデューシャルマーカー市場は、2024年には3,230万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 8.0%で推移し、2030年には予測市場規模3,780万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ2.8％と4.1％と予測されています。欧州では、ドイツがCAGR約3.5%で成長すると予測されています。

世界のフィデューシャルマーカー市場- 主要動向と促進要因まとめ

医療画像診断および放射線治療におけるフィデューシャルマーカーの需要を牽引しているのは？

フィデューシャルマーカーは、画像診断や放射線治療の精度を高めるため、医療分野、特に腫瘍学において需要が高まっています。フィデューシャルマーカーは、腫瘍内や腫瘍近傍に設置される金属やポリマーの小さなマーカーであることが多く、体内の腫瘍の正確な位置を特定するのに役立ち、定位体放射線治療（SBRT）や強度変調放射線治療（IMRT）などの治療において、医師がターゲティング精度を向上させることを可能にします。この精度により、周囲の健康な組織へのダメージが軽減され、その結果、副作用が減少し、患者の転帰が改善されます。世界的にがん患者が増加する中、フィデューシャルマーカーは前立腺がん、肺がん、肝臓がんなど様々な種類のがんに放射線量を正確に照射するために高い需要があります。

フィデューシャルマーカーは、放射線治療以外にも、CT、MRI、超音波などの画像診断技術にも使用され、低侵襲手術や生検の際に腫瘍やその他の構造を可視化するのに役立っています。個々の患者のニーズに合わせて治療を行う精密医療への注目の高まりは、フィデューシャルマーカー市場の主な促進要因であり、特に北米や欧州のような高度なヘルスケアインフラを持つ地域では、正確さと低侵襲技術が優先されます。

技術の進歩はフィデューシャルマーカーの開発にどのような影響を与えていますか？

材料科学とマーカーデザインの技術的進歩により、フィデューシャルマーカーの安全性、視認性、生体適合性が向上しています。金、プラチナ、生分解性ポリマーの使用を含むマーカー材料の革新は、フィデューシャルマーカーの体内での安定性と適合性を向上させます。例えば金マーカーは、画像スキャンで高い視認性を提供すると同時に、非反応性で患者にとって安全であるため、長期間の留置に適しています。さらに、徐々に溶解する生分解性マーカーは外科的除去の必要性を減らし、患者の快適性と利便性を向上させる。

ヘリカルマーカーやマルチセグメントマーカーなどの先進的なデザインは、軟部組織内での固定性を向上させ、移動を防ぎ、正確なターゲティングのための安定した配置を保証します。マーカーはまた、MRIガイド下治療を受ける患者のためのMRI適合マーカーなど、特定の画像モダリティに適合するように設計されています。このような技術的進歩により、フィデューシャルマーカーの応用範囲は拡大し、患者の安全性と快適性を高めながら、治療と画像診断の精度を向上させています。

精密医療と低侵襲の動向は、フィデューシャルマーカー市場の形成にどのような役割を果たしていますか？

精密医療と低侵襲治療へのシフトは、フィデューシャルマーカーの需要を促進しています。これらのアプローチは、正確さと個別化された治療を重視しているからです。フィデューシャルマーカーは、腫瘍の位置を特定し、リアルタイムの画像ガイダンスをサポートするという重要な役割を担っています。これは、標的治療を提供し、低侵襲治療で良好な結果を得るために不可欠です。例えば、前立腺がんの治療では、フィデューシャルマーカーは正確な放射線照射を可能にし、隣接臓器を損傷するリスクを低減します。

低侵襲手術は、アクセスポイントが限られているため、正確な視覚化に大きく依存しています。フィデューシャルマーカーを使用することで、外科医や放射線技師は、これらの処置中に高い精度を維持することができ、成功率を向上させ、回復時間を短縮することができます。ヘルスケアシステムが、正確さを優先し、副作用を最小限に抑える患者中心のケアに重点を置く中、フィデューシャルマーカーは治療と診断の両方の場面で不可欠なツールになりつつあります。

フィデューシャルマーカー市場の成長を促進する要因は？

フィデューシャルマーカー市場の成長は、がん罹患率の上昇、精密画像および放射線治療の進歩、低侵襲技術の採用、個別化治療の需要によってもたらされます。前立腺がん、肺がん、肝臓がんなどの発生率が高まる中、フィデューシャルマーカーは治療の精度を高め、周辺組織へのダメージを最小限に抑える上で重要な役割を果たしています。MRI適合や生分解性のオプションなど、マーカーの素材やデザインにおける革新は、様々な治療法への応用を拡大し、効果と患者の経験の両方を向上させています。

精密医療や低侵襲治療への動きも、フィデューシャルマーカーがリアルタイムイメージングやこれらのアプローチにおける標的治療を可能にするため、成長の原動力となっています。先進的ながん治療に対する世界の認識と投資の増加により、フィデューシャルマーカーは個別化され、精度に焦点を当てたヘルスケア戦略に不可欠な要素となっています。がん罹患率の上昇、技術の進歩、精密医療、低侵襲の動向といったこれらの要因が相まって、フィデューシャルマーカー市場の力強い成長が促進され、現代医療における治療精度と患者の転帰を改善する役割を支えています。

セグメント

製品タイプ（金属、ポリマー、その他の製品タイプ）、モダリティ（CT/CBCT、MRI、超音波、放射線治療）、エンドユーザー（病院および外来患者施設、独立放射線治療センター、がん研究センター）

調査対象企業の例

  • Beekley Corporation
  • Best Medical International, Inc.
  • Boston Scientific Corporation
  • Carbon Medical Technologies
  • CIVCO Radiotherapy
  • Eckert & Ziegler
  • IBA
  • Innomedicus AG
  • Innovative Oncology Solutions
  • IZI Medical Products
  • JJ-Medtech
  • Meditronix Corporation
  • Medtronic
  • Nanovi A/S
  • Naslund Medical AB
  • QFIX
  • QlRad Inc.
  • Seedos Ltd
  • Stellar Medical
  • Varian Medical Systems, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21784

Global Fiducial Markers Market to Reach US$166.4 Million by 2030

The global market for Fiducial Markers estimated at US$123.8 Million in the year 2024, is expected to reach US$166.4 Million by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Metal, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$76.2 Million by the end of the analysis period. Growth in the Polymer segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$32.3 Million While China is Forecast to Grow at 8.0% CAGR

The Fiducial Markers market in the U.S. is estimated at US$32.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$37.8 Million by the year 2030 trailing a CAGR of 8.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.8% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Fiducial Markers Market - Key Trends & Drivers Summarized

What Is Driving Demand for Fiducial Markers in Medical Imaging and Radiation Therapy?

The demand for fiducial markers is increasing in the medical field, particularly in oncology, as they enhance precision in imaging and radiation therapy. Fiducial markers, often small metal or polymer markers placed in or near tumors, help define the exact location of a tumor within the body, enabling doctors to improve targeting accuracy in treatments like stereotactic body radiotherapy (SBRT) and intensity-modulated radiation therapy (IMRT). This precision reduces damage to surrounding healthy tissues, resulting in fewer side effects and improved patient outcomes. As cancer cases rise globally, fiducial markers are in high demand for accurately delivering radiation doses to various cancer types, such as prostate, lung, and liver cancers.

In addition to radiotherapy, fiducial markers are also used in diagnostic imaging techniques like CT, MRI, and ultrasound to help visualize tumors and other structures during minimally invasive surgeries and biopsy procedures. The growing focus on precision medicine, which tailors treatment to individual patient needs, is a major driver of the fiducial markers market, particularly in regions with advanced healthcare infrastructure, such as North America and Europe, where accuracy and minimally invasive techniques are prioritized.

How Are Technological Advancements Impacting the Development of Fiducial Markers?

Technological advancements in materials science and marker design are enhancing the safety, visibility, and biocompatibility of fiducial markers. Innovations in marker materials, including the use of gold, platinum, and biodegradable polymers, improve the stability and compatibility of fiducial markers within the body. Gold markers, for instance, offer high visibility on imaging scans while remaining non-reactive and safe for patients, making them suitable for long-term placement. Additionally, biodegradable markers that gradually dissolve reduce the need for surgical removal, enhancing patient comfort and convenience.

Advanced designs, such as helical and multi-segment markers, improve fixation within soft tissues, preventing migration and ensuring stable placement for accurate targeting. Markers are also being designed for compatibility with specific imaging modalities, such as MRI-compatible markers for patients undergoing MRI-guided treatments. These technological advancements are expanding the application of fiducial markers, improving the accuracy of treatment and imaging while enhancing patient safety and comfort.

What Role Do Precision Medicine and Minimally Invasive Trends Play in Shaping the Fiducial Markers Market?

The shift toward precision medicine and minimally invasive procedures is driving demand for fiducial markers, as these approaches emphasize accuracy and personalized treatment. Fiducial markers play a crucial role in localizing tumors and supporting real-time imaging guidance, which is essential for delivering targeted therapies and achieving favorable outcomes in minimally invasive procedures. For instance, in prostate cancer treatments, fiducial markers allow for precise radiation targeting, reducing the risk of damaging adjacent organs.

Minimally invasive procedures rely heavily on accurate visualization, as they involve limited access points. Fiducial markers enable surgeons and radiologists to maintain high levels of precision during these procedures, improving success rates and reducing recovery times. As healthcare systems focus on patient-centric care that prioritizes accuracy and minimizes side effects, fiducial markers are becoming indispensable tools in both therapeutic and diagnostic settings.

What Factors Are Driving Growth in the Fiducial Markers Market?

The growth in the fiducial markers market is driven by the rise in cancer prevalence, advancements in precision imaging and radiotherapy, the adoption of minimally invasive techniques, and the demand for personalized treatment. As the incidence of cancers such as prostate, lung, and liver cancers increases, fiducial markers play a critical role in improving the accuracy of treatment and minimizing damage to surrounding tissues. Innovations in marker materials and designs, including MRI-compatible and biodegradable options, have expanded their application in various treatment modalities, enhancing both effectiveness and patient experience.

The move toward precision medicine and minimally invasive procedures is also driving growth, as fiducial markers enable real-time imaging and targeted treatment in these approaches. With increasing awareness and investment in advanced cancer treatments globally, fiducial markers are becoming essential components of personalized and precision-focused healthcare strategies. Together, these factors-rising cancer rates, technological advancements, precision medicine, and minimally invasive trends-are propelling robust growth in the fiducial markers market, supporting its role in improving treatment accuracy and patient outcomes in modern medicine.

SCOPE OF STUDY:

The report analyzes the Fiducial Markers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Metal, Polymer, Other Product Types); Modality (CT / CBCT, MRI, Ultrasound, Radiotherapy); End-Use (Hospitals & Outpatient Facilities, Independent Radiotherapy Centers, Cancer Research Centers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Beekley Corporation
  • Best Medical International, Inc.
  • Boston Scientific Corporation
  • Carbon Medical Technologies
  • CIVCO Radiotherapy
  • Eckert & Ziegler
  • IBA
  • Innomedicus AG
  • Innovative Oncology Solutions
  • IZI Medical Products
  • JJ-Medtech
  • Meditronix Corporation
  • Medtronic
  • Nanovi A/S
  • Naslund Medical AB
  • QFIX
  • QlRad Inc.
  • Seedos Ltd
  • Stellar Medical
  • Varian Medical Systems, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Fiducial Markers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer and Need for Accurate Tumor Localization Drives Demand for Fiducial Markers in Radiation Therapy
    • Growing Focus on Precision Medicine Propels Use of Fiducial Markers in Personalized Cancer Treatment Protocols
    • Technological Advancements in Imaging Techniques, Including MRI and CT Compatibility, Strengthen the Business Case for Fiducial Markers
    • Increasing Adoption of Fiducial Markers in Minimally Invasive Procedures Expands Market for Marker-Assisted Surgeries
    • Expanding Role of Fiducial Markers in Biopsy and Tumor Mapping Applications Drives Demand in Diagnostic Oncology
    • Rising Use of Image-Guided Radiotherapy (IGRT) and Stereotactic Body Radiotherapy (SBRT) Propels Market for High-Precision Fiducial Markers
    • Development of Biodegradable and Bio-Inert Fiducial Markers Enhances Safety and Expands Clinical Applications
    • Growing Demand for Real-Time Tracking in Complex Radiotherapy Treatments Spurs Innovations in Marker Design and Materials
    • Increased Focus on Patient Comfort and Reduced Complications Drives Development of Smaller, More Versatile Fiducial Markers
    • Advancements in Robotic-Assisted Surgeries Highlight Fiducial Markers as Essential for Accurate Surgical Navigation
    • Expanding Applications of Fiducial Markers in Neurology and Brain Mapping Increases Market Potential in Neurosurgery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fiducial Markers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Metal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Metal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cancer Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cancer Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cancer Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Hospitals & Outpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Hospitals & Outpatient Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Hospitals & Outpatient Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Independent Radiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Independent Radiotherapy Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Independent Radiotherapy Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for CT / CBCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for CT / CBCT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for CT / CBCT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Radiotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Radiotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 30: World 15-Year Perspective for Radiotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 31: World Fiducial Markers Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Canada 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • JAPAN
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Japan 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • CHINA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 62: China Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: China 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 65: China Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • EUROPE
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Fiducial Markers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Europe 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • FRANCE
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 83: France Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: France 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 86: France Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • GERMANY
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Germany 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Italy 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 110: UK Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: UK 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 113: UK Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Spain 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Russia 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Fiducial Markers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Australia 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • INDIA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 167: India Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: India 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 170: India Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: South Korea 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Fiducial Markers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Latin America 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Argentina 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: Brazil 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: Mexico 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Latin America 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Fiducial Markers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Middle East 15-Year Perspective for Fiducial Markers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Iran 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Israel 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Saudi Arabia 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: UAE 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Rest of Middle East 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030
  • AFRICA
    • Fiducial Markers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Fiducial Markers by Product Type - Metal, Polymer and Other Product Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Africa 15-Year Perspective for Fiducial Markers by Product Type - Percentage Breakdown of Value Sales for Metal, Polymer and Other Product Types for the Years 2015, 2025 & 2030
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Fiducial Markers by End-Use - Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Fiducial Markers by End-Use - Percentage Breakdown of Value Sales for Cancer Research Centers, Hospitals & Outpatient Facilities and Independent Radiotherapy Centers for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Fiducial Markers by Modality - CT / CBCT, MRI, Ultrasound and Radiotherapy Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Fiducial Markers by Modality - Percentage Breakdown of Value Sales for CT / CBCT, MRI, Ultrasound and Radiotherapy for the Years 2015, 2025 & 2030

IV. COMPETITION